SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending downwards as investors react to increased spending forecasts related to AI, drawing comparisons to the company's metaverse investments; the community is debating whether this dip represents a buying opportunity or signals deeper concerns about Meta's direction, with some citing a one-time tax charge as the primary driver, while others point to overall market weakness or algorithmic reactions.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the iconic Rage Guy meme, emphasizing a return to OG meme culture and community-driven growth. Discussions highlight the importance of belief and shared effort, with community members expressing bullish sentiment and encouraging each other to "RAGE ON" and "work for their bags". The movement is positioned as a cultural correction against soulless memecoins.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors anticipate the company's earnings report and how effectively it's monetizing data through AI partnerships. Community members are discussing revenue estimates, daily active user growth, and the potential for a post-earnings rally or selloff. Some are also pointing to potential connections with other trending stocks and broader market factors.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific (CORZ) is trending as shareholders prepare to vote on a proposed merger with CoreWeave ($CRWV); discussions center on whether the deal undervalues CORZ, especially given the potential for AI infrastructure growth. Some shareholders believe CORZ is worth more as a standalone company, citing peers and potential for new contracts, while others worry about financial stability without the merger. The vote outcome is uncertain, leading to speculation about future directions and potential board changes.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is trending downwards as the community discusses concerns around declining traffic, margin pressures, and lowered sales outlook, potentially driven by consumer spending habits and pricing. Some traders believe the stock is oversold, presenting a buying opportunity, while others express concerns about the company's current leadership and competitive landscape. Community members are also debating if a change in strategy is needed to better appeal to a broader customer base.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent BioSolutions is trending due to renewed optimism fueled by raised FY25 EBITDA guidance and a potential short squeeze, with the community actively discussing target prices and the possibility of further upside. A top-line Q3 beat and recent earnings surprise are adding to the positive sentiment. Some traders are closely monitoring the stock's short interest and anticipating a significant price movement.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid unconfirmed rumors of a potential buyout, sparking active discussions within the investment community. The speculation surfaces as the company focuses on oncology and prepares to report earnings in November. Community members are weighing the potential deal price and strategic implications for Moderna's future.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as community members discuss the potential for a short squeeze, driven by high short interest and optimism around the company's pipeline. Chatter revolves around buyout speculation, comparisons to competitors, and anticipation for upcoming presentations at ObesityWeek. The stock's recent performance and market dynamics in the obesity treatment sector are also fueling the conversation.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is trending as investors digest recent earnings and a reduced dividend, leading to a sharp price decline. The community is debating whether this presents a value opportunity or signals deeper challenges for the company, with some citing an overreaction and oversold conditions. Bullish sentiment is building around potential for a price rebound given its inclusion in the S&P 500.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending due to upcoming Phase 3 data for its DMD treatment, with investors closely watching for positive results that could lead to FDA approval; community chatter reflects both excitement and apprehension, as the data represents a pivotal moment for the company. Community members also highlight BlackRock's substantial stake in Capricor. Some traders cite the potential for a significant short squeeze based on the stock's high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Tilray Brands (TLRY) soared 19% in the pre-market session on Thursday after the company reported adjusted net income of $3.9 million for the first quarter, marking a turnaround from a loss of $6.1 million reported in the corresponding quarter of 2024.The company’s net revenue increased 5% to $209.5 million in the quarter, driven by a rise in cannabis net revenue, and beating an analyst estimate of $206 million, according to data from Koyfin. On an adjusted basis, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/09/3164004/0/en/Tilray-Brands-Reports-Strong-First-Quarter-Fiscal-2026-Results-Highlighting-Continued-Growth-with-Record-Q1-Net-Revenue-of-210-Million-and-Net-Income.html">reported</a> nil earnings per share for the quarter, compared to a loss of $0.04 in the corresponding quarter of the last fiscal year. &nbsp;The cannabis and beverage firm also said that it reduced its total outstanding debt by $7.7 million in the three months in a bid to strengthen its balance sheet. The company ended the quarter with a cash balance of $264.8 million.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.A Stocktwits user expressed hopes for the company's future, particularly in light of the possibility of positive cannabis legislation.<stembedurl>https://stocktwits.com/Family2328/message/631626082</stembedurl>Another user expects the company to hit profitability soon.<stembedurl>https://stocktwits.com/Yakish/message/631626201</stembedurl>Last month, U.S. President Donald Trump shared a video promoting cannabis use for seniors and medicaid coverage of cannabis products, sending shares of Tilray soaring.For fiscal year 2026, the company now expects to report adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $62 million to $72 million.TLRY stock is up by 29% this year and by about 6% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-faces-nhtsa-probe-into-2.9-million-fsd-equipped-vehicles/ch67VsCR3K9">Tesla Faces NHTSA Probe Into 2.9M FSD-Equipped Vehicles</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

Tilray Brands Stock Skyrockets On Swing To Profit, Significant Debt Reduction

The company said that it reduced its total outstanding debt by $7.7 million in the three months in a bid to strengthen its balance sheet.

Equity

Retail investors on Stocktwits are optimistic about Genius Group’s pivot and hope to see the same returns as MicroStrategy after the latter pivoted to a Bitcoin-first strategy in 2020. | Source: Pixabay

Why Is Genius Group Stock Rising Today?

Genius Group repurchased its stock on the open market at an average price of $0.90 per share from August 28 to September 11, 2025.

Shares of Milestone Pharmaceuticals Inc. (MIST) traded 60% lower on Friday after the Food and Drug Administration (FDA) did <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/03/28/3051260/0/en/FDA-Issues-Complete-Response-Letter-for-Etripamil-for-PSVT.html">not approve</a> its lead investigational product, Cardamyst.The nasal spray is under development to treat episodes of abnormal heart rhythm associated with Paroxysmal supraventricular tachycardia (PSVT).The FDA highlighted two key Chemistry, Manufacturing and Controls (CMC) issues.The regulator asked the company to submit additional information on nitrosamine impurities based on the new draft guidance issued after the New Drug Application (NDA) submission. &nbsp;The agency also said an inspection is required at a facility where the company performed release testing for the product to ensure it complies with Current Good Manufacturing Practices.Milestone Pharmaceuticals CEO Joe Oliveto said that the company is “deeply disappointed” by the letter but remains committed to the potential of the drug in treating patients with PSVT.“Our team is evaluating the feedback provided and intends to request a Type A meeting to discuss the issues raised in the CRL,” Oliveto said. “We are appreciative of the FDA’s efforts and are confident we can collaborate with the agency with the goal of addressing these issues in a resubmission.”The FDA did not raise any concerns regarding the drug’s clinical safety or efficacy, the company said.The nasal spray has been designed as a self-administered rapid response therapy, thereby bypassing the need for immediate medical oversight, it explained.On Stocktwits, retail investor sentiment about Milestone Pharmaceuticals dropped slightly within the ‘extremely bullish’ territory (89/100), while message volume remained at ‘extremely high’ levels over the past 24 hours.<figure class="image"><img style="aspect-ratio:652/152;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_28_at_12_10_06_PM_png_e7518f6d31.webp" alt="MIST's Sentiment Meter and Message Volume as of 12:10 p.m. ET on March 28, 2025 | Source: Stocktwits" width="652" height="152"><figcaption>MIST's Sentiment Meter and Message Volume as of 12:10 p.m. ET on March 28, 2025 | Source: Stocktwits</figcaption></figure>Following the company’s announcement, HC Wainwright kept a ‘Buy’ rating on Milestone pharmaceuticals and noted that the FDA flagged no concerns around the efficacy of the product, thereby reaffirming the integrity of the clinical data.However, the firm expects the product's launch to be delayed until the first half of 2026.<a href="https://stocktwits.com/symbol/MIST">Shares of Milestone Pharmaceuticals</a> fell over 55% this year and by over 45% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/hyperscale-data-shares-drop-despite-completing-first-nvidia-gpu-installation/chJ3iDORbEC">Hyperscale Data Stock Drops Despite Completing First Nvidia GPU Installation – But Retail Turns Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s Positive 

The FDA said an inspection is required at a facility where the company performed release testing for the product to ensure it complies with Current Good Manufacturing Practices.

Shares of education platform Genius Group&nbsp;were in the spotlight on Monday morning&nbsp;after the company&nbsp;announced that it had acquired an additional 105 Bitcoin for $10 million, bringing its total Bitcoin holdings to 319 tokens.After dropping over 2% in early morning trade, the stock was up over 4% at last check.The company reiterated its "Bitcoin-first" strategy, which was unveiled in November. Genius Group plans to allocate 90% or more of its reserves to Bitcoin, with an initial goal of accumulating $120 million worth of the cryptocurrency.&nbsp;In the six weeks since announcing the strategy, the company has spent $30 million to acquire 319.4 Bitcoin at an average price of $93,919 per token. The purchase represents 25% of the company’s initial Bitcoin target, exceeding its internal timeline.<figure class="image"><a href="https://bitcointreasuries.net/entities/genius-group" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1251/199;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_30_104353_5fc87e866a.png" alt="Screenshot 2024-12-30 104353.png" width="1251" height="199"></a><figcaption>Genius Group's Bitcoin Purchases Over The Last 6 Weeks | Source:BitcoinTreasuries</figcaption></figure>The move mirrors the treasury strategy employed by Michael Saylor-owned MicroStrategy, which has been announcing its Bitcoin purchases every Monday.&nbsp;Genius Group's CEO has framed the shift as a long-term commitment to the digital asset, emphasizing its role in safeguarding company reserves amid a volatile economic climate.<figure class="image"><img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_30_105112_8808c47a6c.png" alt="Screenshot 2024-12-30 105112.png"><figcaption>Genius Group Ltd. Sentiment and Message Volume on Dec 30 as of 10:50 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around Genius Group improved to ‘bullish’ from ‘neutral’ as chatter also increased to ‘normal’ levels from ‘level’ a day ago.&nbsp;Users debated whether or not the current levels of dilutions are sustainable.<stembedurl>https://stocktwits.com/sunkissed1/message/598192228</stembedurl><stembedurl>https://stocktwits.com/Mysticx24/message/598185932</stembedurl>Others celebrated that the company now has Bitcoin worth $30 million in its coffers.&nbsp;<stembedurl>https://stocktwits.com/EarlofLondon/message/598180299</stembedurl><stembedurl>https://stocktwits.com/warrants_Moon/message/598175305</stembedurl><stembedurl>https://stocktwits.com/22Shares/message/598179161</stembedurl>According to the company, the next step is to focus on maximizing its BTC Yield – a Bitcoin Treasury key performance indicator (KPI), initiated by Saylor for Microstrategy.“Now, with a focus on BTC Yield KPI, we are considering various investment and finance options that maximize shareholder value whilst accelerating our progress in building our Bitcoin Treasury,” said CEO Roger Hamilton.Since November, the company has achieved a BTC Yield of 1,646% so far.&nbsp;However, the stock has dipped nearly 90% this year, trading near its 52-week low of $0.51 and far from its 52-week high of $7.08.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mara-riot-hut-crypto-stocks-take-a-hit-as-bitcoin-dips/cJOiPdWRkf">Bitcoin’s Drop To $93K Drags BTC Mining Stocks: Retail Sentiment Remains Frosty</a>

Genius Group Stock Swings After Announcing Bitcoin Buy Worth $10M: Retail Sentiment Improves

In the six weeks since announcing its shift in its treasury strategy, Genius Group has spent $30 million to acquire 319.4 Bitcoin.

Several cannabis stocks dived on Wednesday after Democrat Vice President Kamala Harris lost to Republican candidate Donald Trump, who will return for a second term in the White House to become the 47th U.S. president.Harris was seen as having a favorable take on the recreational use of Cannabis, which many Republican states have yet to legalize.On Wednesday, the state of Florida voted against one such move that would have legalized marijuana for recreational use to adults 21 years of age and older from medical marijuana treatment centers and other state-licensed entities, Reuters <a target="_blank" rel="noopener noreferrer nofollow" href="https://reported.">reported.</a>Florida was seen as a &nbsp;“very attractive market,” Reuters reported citing an estimate from cannabis analytics company Headset <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/markets/us/pot-stocks-dive-florida-rejects-legalization-recreational-marijuana-2024-11-06/">indicating</a> $4.9 billion to $6.1 billion in adult-use sales during the first year of implementation.Cannabis-focused stocks such as Tilray Brands ($TLRY) and Trulieve ($TCNNF) were down 14% and 39% respectively as of 1:55 pm ET. &nbsp;Trulieve had also provided funding worth $145 million as of October towards the Florida campaign, Associated Press <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.marketwatch.com/story/florida-ballot-measures-for-abortion-rights-legalized-marijuana-fail-f70b1bbe?mod=home-page&amp;mod=article_inline">reported.</a>Other stocks that saw declines include US-listed SNDL Inc. ($SNDL) and Cronos Group ($CRON) were down 14% and 9%, respectively as of 2:20 pm ET. &nbsp;While shares of Canada-based Aurora Cannabis Inc. ($ACB) were down more than 17% as of 2:45 pm ET.To be sure, Trump’s choice of who replaces the current attorney general and the possibility of a more moderate senate majority leader may still bring favor to the industry.Twenty four American states have legalized cannabis for recreational use, with 39 states where Cannabis use is allowed for medical purposes.Many Stocktwits users were hopeful of a bounce back.<stembedurl>https://stocktwits.com/RizzaSizzler/message/591429531</stembedurl><stembedurl>https://stocktwits.com/Goldenleaf/message/591435127</stembedurl><stembedurl>https://stocktwits.com/CoBear/message/591441354</stembedurl> &nbsp;For updates and corrections, email newsroom@stocktwits.com.&nbsp;

Cannabis-focused companies like $CRON, $ACB, $SNDL saw stocks slip | Source: Pexels

 US Election 2024: Cannabis Stocks Feel Trump Effect, But Retail's Hopes Stay High

Harris was seen as having a favorable take on the recreational use of Cannabis

Shares of Canada-based Aurora Cannabis Inc. ($ACB) jumped more than 2% on Tuesday, ahead of the cannabis producer’s third-quarter earnings, lifting retail sentiment.Edmonton, Canada-based Aurora makes cannabis and cannabis-derived products sold under brands such as ‘Cannimed’, “Bidiol’ and ‘Being.’Wall Street analysts expect Aurora to report earnings per share (EPS) of $0.08 on estimated revenues of $50.73 million.Retail sentiment on the stock has inched lower compared to a day ago but remains ‘extremely bullish,’ with ‘high’ message volumes.<figure class="image"><img style="aspect-ratio:1316/352;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_11_06_at_5_38_03_AM_1920c18130.png" alt="Screenshot 2024-11-06 at 5.38.03 AM.png" width="1316" height="352"><figcaption>ACB sentiment meter and message volumes on Nov 5 as of 7:09 pm ET</figcaption></figure>According to The Fly.com, Aurora was seeing ‘bullish’ option flow with 4,183 calls trading, 2.0x expected, and implied volume increasing over 32 points to 379.40%.Earlier this week, BofA said broad-based tariffs were likely under a Trump win that will influence consumer stocks including cannabis stocks. According to the firm, a broad cannabis reform is likely with relaxed regulatory standards. Several cannabis-focused companies stand to benefit from this including Aurora, CV Sciences ($CVSI), and Truelieve Cannabis (TCNNF).Many Stocktwits users were upbeat about the company’s stock even with the regulatory uncertainty related to the election outcomes.<stembedurl>https://stocktwits.com/NoFearHere/message/590887046</stembedurl><stembedurl>https://stocktwits.com/Peteey/message/590812825</stembedurl>Aurora stock is up 28.74% year-to-date.For updates and corrections, email newsroom@stocktwits.com&nbsp;

Wall Street analysts expect Aurora to report earnings per share (EPS) of $0.08 on estimated revenues of $50.73 million.| Image source: Pixabay

Aurora Cannabis Stock Surges Ahead of Q3 Earnings: Retail Sentiment Strong

Retail sentiment on the stock has been strong, with ‘extremely bullish’ sentiment scores and ‘high’ message volumes.

SSgA Active Trust - SPDR S&P International Small Cap ETF

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

Current Price	$40.04
Prev Close	$40.13
Open	$39.84
Dividend Yield	N/A
50-Day Moving Average	$39.98
Beta	N/A
Avg. Volume	42,344.76
PE Ratio	N/A

52-Week High	$40.96
52-Week Low	$28.53
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

GWX
SPDR S&P International Small Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest GWX News

GWXSPDR S&P International Small Cap ETF